Non-alcoholic fatty liver disease (NAFLD) is an important public health problem with growing
numbers of NAFLD patients worldwide. Pathological conditions are different in each stage of …

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
emerging as the leading causes of liver disease worldwide. These conditions can lead to …

Nonalcoholic fatty liver disease (NAFLD) has become the most common liver disease in the
United States and other developed countries and is expected to increase in the next few …

The liver is the site of first pass metabolism, detoxifying and metabolizing blood arriving from
the hepatic portal vein and hepatic artery. It is made up of multiple cell types, including …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing all around the
world and it may become the primary cause of terminal liver disease in adults and children …

Nonalcoholic fatty liver disease (NAFLD) includes a series of hepatic manifestations, starting
with liver steatosis and potentially evolving towards nonalcoholic steatohepatitis (NASH) …

Non-alcoholic fatty liver disease (NAFLD) includes a variety of histological conditions
(ranging from liver steatosis and steatohepatitis, to fibrosis and hepatocarcinoma) that are …

Macrophages have diverse phenotypes and functions due to differences in their origin,
location and pathophysiological context. Although their main role in the liver has been …

Introduction: Nonalcoholic fatty liver disease (NAFLD) is the most widespread chronic liver
disease in the world. It can evolve into nonalcoholic steatohepatitis (NASH) where …

Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most prevalent cause of
liver disease worldwide and afflicts adults and children as currently associated with obesity …